Financial Data and Key Metrics Changes - The company reported total revenue for Q2 2025 of $1.4 billion, down from $1.48 billion in Q2 2024, primarily due to lower risk adjustment contributions and unfavorable developments in Part D costs [29][30] - Medical margin for Q2 2025 was negative $53 million, compared to positive $106 million in Q2 2024, driven by underperformance in the burden of illness program [30][33] - Adjusted EBITDA for Q2 2025 was negative $83 million, compared to negative $3 million in Q2 2024, reflecting the impact of lower risk adjustments and unfavorable prior period developments [33] Business Line Data and Key Metrics Changes - Medicare Advantage membership at the end of Q2 2025 was 498,000, down from 513,000 in Q2 2024, reflecting a measured approach to membership growth [28] - ACO REACH membership in Q2 2025 was 116,000, down from 132,000 in 2024, aligning with expectations [28] Market Data and Key Metrics Changes - The company has reduced its exposure to Medicare Part D, with less than 30% of its membership carrying Part D risk in 2025, and aims to further decrease this as it enters 2026 [35] - The company expects its same geography growth rate to align with the broader industry for 2025 [28] Company Strategy and Development Direction - The company is focused on improving contract economics and bid visibility with payers, enhancing its data platform, and reducing variability in its business [36] - The leadership transition aims to drive improved execution and strengthen relationships critical to future success [10][11] - The company is committed to enhancing performance and Agilent's position for sustainable value creation, particularly with the improved Medicare reimbursement model expected to take effect next year [14] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that 2025 is a transition year with industry complexities and headwinds that were more acute than previously expected, leading to underperformance [8][9] - The company is optimistic about realizing the benefits of strategic initiatives in 2026, despite current challenges [7][36] Other Important Information - The company has withdrawn its previously issued full-year 2025 financial guidance due to ongoing market uncertainty [35] - The leadership team is recalibrating the organization's culture to emphasize urgency, accountability, and performance [11] Q&A Session Summary Question: Clarification on potential positive PYD in Q3 and growth rate into 2026 - Management indicated that there was a small amount of favorable development on quality programs, but the most significant pieces of development were unfavorable, particularly related to risk adjustment [40][41][42] Question: Insights on call trends and cost trends - Cost trends for Q1 were around 6%, and Q2 trends were consistent with Q1, but July data was not yet complete [46][47] Question: Commentary on 2026 class and glide path strategy - Management confirmed that growth for 2026 is under review and will be highly selective based on current business performance [59] Question: Insights on bidding for 2026 - Management noted that payers are looking for improved economics as they head into 2026, and negotiations are ongoing [61][62] Question: CEO search criteria - The company is looking for a CEO with multi-market management capability, experience with primary care physicians, and operational rigor [68][69] Question: Quality incentives and their potential impact - Management expects an increase in quality incentive dollars from 2025 to 2026, as payers are more willing to put dollars at risk for higher performance [75][76]

Financial Data and Key Metrics Changes - The company achieved over $1 billion in quarterly revenue for the first time, with overall revenue growth accelerating to 48% year over year in Q2 [5][21] - The Rule of 40 score reached 94 in Q2, up 11 points quarter over quarter, indicating strong revenue growth and profitability [5][34] - Adjusted operating margin expanded to 46%, exceeding prior guidance by nearly 300 basis points [23][34] Business Line Data and Key Metrics Changes - U.S. Commercial revenue grew 93% year over year and 20% sequentially, now comprising 31% of total revenue [10][22] - U.S. Government revenue grew 53% year over year and 14% sequentially, driven by new contracts and existing program execution [12][29] - International commercial revenue declined 3% year over year but grew 2% sequentially, with a focus on targeted growth opportunities [28] Market Data and Key Metrics Changes - Total remaining deal value in the U.S. Commercial business grew 145% year over year and 20% sequentially [27] - Net dollar retention increased to 128%, reflecting expansions at existing customers and new customer acquisitions [30] - Customer count grew 43% year over year to 849 customers, with revenue from the top 20 customers increasing 30% year over year [25] Company Strategy and Development Direction - The company is focused on delivering AI production impact, with significant expansions in existing customer contracts and new customer acquisitions [11][17] - Investments in ontology and infrastructure are positioned to uniquely meet AI demand, with a strong emphasis on integrating LLMs and workflow [14][15] - The company aims to empower frontline workers and enhance productivity through AI, emphasizing the importance of agency and creativity in the workforce [18][49] Management's Comments on Operating Environment and Future Outlook - Management expressed high enthusiasm for the business outlook, citing strong demand for AI solutions and the transformative impact of their products [13][21] - The company anticipates continued growth in the second half of the year, with guidance for Q3 revenue between $1.083 billion and $1.087 billion [36] - Management highlighted the importance of maintaining a strong talent pool and fostering an environment that attracts and retains top talent [70][73] Other Important Information - The company closed $2.3 billion in total contract value (TCV) bookings, marking a 140% year-over-year increase [30] - Adjusted free cash flow for Q2 was $569 million, representing a margin of 57% [35] - The company is committed to investing in elite technical talent and expanding its product pipeline while maintaining GAAP profitability [34] Q&A Session Summary Question: How is Palantir making AI more useful for frontline workers and decision makers? - Management emphasized that AI is empowering American workers, allowing them to focus on critical tasks rather than administrative burdens [48][49] Question: Will the company pursue a direct sales force given its current growth? - Management indicated that while there will be some direct salespeople, the primary sales force will be current customers advocating for the company's products [53][54] Question: What excites the company about the recent AI action plan from the White House? - Management expressed excitement about the recognition of the need for an American open AI tech stack and the focus on implementation [67][68] Question: How does the company ensure it attracts and retains top talent? - Management highlighted the importance of providing access to meaningful problems and creating a culture that values agency and creativity [70][73]

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $217.1 million, an 11% increase from $195.9 million in Q2 2024 [24] - U.S. revenue was $207.2 million, a 10% increase from $187.8 million in the prior year [24] - Gross margin decreased to 84% from 84.8% year over year, primarily due to a $2.1 million charge for excess INSPIRE IV subcomponents [24] - Operating loss for the quarter was $3.3 million compared to an operating income of $5.1 million in the prior year [26] - Net loss for the quarter was $3.6 million, compared to a net income of $9.8 million in the prior year [26] - Adjusted EBITDA for the quarter was $44.1 million, a 14% increase compared to $38.7 million in the prior year [27] - Adjusted net income per share increased by 40% year over year to $0.45 [27] Business Line Data and Key Metrics Changes - The majority of units sold in Q2 were INSPIRE IVs, leading to minimal inventory destocking [10] - Over 50% of U.S. centers have completed the implementation of SleepSync, which is crucial for the transition to INSPIRE V [9] - The company is experiencing a 20% increase in patient implants at U.S. centers that have transitioned to INSPIRE V compared to the same period in 2024 [15] Market Data and Key Metrics Changes - Revenue outside the U.S. was $9.9 million, a 23% increase year over year [24] - The approval of CPT code 64568 for INSPIRE V for Medicare patients was announced in April, with billing starting on July 1 [11] - The national average Medicare hospital reimbursement for CPT code 64568 is proposed to increase to $32,000, a 4% increase from 2024 [17] Company Strategy and Development Direction - The company is focused on transitioning customers to INSPIRE V and has ramped up marketing and footprint expansion efforts in the second half of the year [12][13] - The company aims to drive high-quality patient flow and increase provider capacity through training and certification of additional surgeons [21] - The company has become a corporate champion of the American Academy of Otolaryngology, enhancing its brand and trust within the ENT community [18] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges in the commercial rollout of INSPIRE V, including delays in training and implementation at centers [7] - The company adjusted its full-year revenue guidance to a range of $900 million to $910 million, reflecting a 4% reduction at the midpoint [14] - Management expressed confidence in overcoming current headwinds and achieving long-term growth [21] Other Important Information - The company ended the quarter with $411 million in cash and investments, allowing it to focus on executing growth strategies [28] - A personnel announcement was made regarding the retirement of Randy Bann, Executive Vice President, Patient Access and Therapy Awareness, in January 2026 [19][20] Q&A Session Summary Question: Can you provide more detail on the revised guidance and the headwinds faced? - Management identified the completion of training and the ability to bill Medicare as the primary factors affecting guidance [34][35] Question: What is the expectation for revenue growth in 2026? - Management expects revenue growth to exceed the 12% to 13% guidance for FY 2025 [37] Question: Can you clarify the EPS guide change? - The reduction in EPS guidance is primarily due to lower revenue expectations and increased marketing costs [41][42] Question: What is the status of the Q3 guidance? - Management anticipates a 1% to 3% sequential increase in Q3 revenue based on patient flow trends [46] Question: What are the underlying volume trends and pressures? - Management noted that the transition to INSPIRE V and the ability to bill Medicare are key factors affecting volume trends [54][55] Question: How is the company addressing the increase in accounts receivable? - The increase is attributed to a transition to a new billing service, which caused temporary delays in invoicing [77] Question: What is the outlook for the fourth quarter? - Management expects a seasonal increase in revenue from Q3 to Q4, consistent with historical trends [96]

Financial Data and Key Metrics Changes - Year-over-year net sales for Q2 2025 were flat at $814 million compared to the same period in 2024 [23] - Gross profit increased to $402 million, up $8 million from $394 million in Q2 2024 [25] - Net income for the quarter rose to $195 million, an increase of $8 million from $187 million in Q2 2024 [25] - Adjusted EBITDA for the quarter was $313 million, reflecting a 4% year-over-year increase [25] - Diluted earnings per share increased by 8% year-over-year to a record $2.29 [26] Business Line Data and Key Metrics Changes - Defense end market net sales increased by 47% year-over-year [23] - Outside North America on-highway end market achieved record quarterly net sales of $142 million, an 11% increase year-over-year, driven by higher demand in South America and Europe [23] - Service parts, support equipment, and other end market net sales increased by 6% year-over-year, primarily due to higher demand for service parts and price increases [24] - Global off-highway end market net sales decreased by 30%, and North America on-highway end market net sales decreased by 9% [24] Market Data and Key Metrics Changes - The company noted a significant increase in demand in South America and Europe, contributing to the growth in the outside North America on-highway end market [23] - The North American on-highway market is experiencing layoffs and production adjustments due to elevated dealer inventories and reduced demand [39][40] Company Strategy and Development Direction - The acquisition of Dana's off-highway business for approximately $2.7 billion is expected to enhance Allison's global footprint and operational capabilities [17][19] - The company anticipates $120 million in annual run rate synergies from the acquisition, primarily through operational efficiencies and procurement [18][21] - Allison aims to leverage Dana's technology centers for local development and cost synergies, enhancing product innovation and engineering capabilities [21][22] Management's Comments on Operating Environment and Future Outlook - Management expressed that current market conditions are viewed as a deferral of demand rather than a permanent decline, with expectations of improved conditions in 2026 [70] - The company is closely monitoring regulatory changes, including EPA emissions regulations, which may impact customer purchasing behavior [70] - Management remains optimistic about the defense market and expects continued growth in that segment [55] Other Important Information - The company revised its full-year 2025 guidance, expecting net sales to be in the range of $3.75 billion to $3.175 billion [28] - Capital expenditures are anticipated to be between $165 million and $175 million, with adjusted free cash flow expected in the range of $620 million to $660 million [28] Q&A Session Summary Question: Can you expand on the potential for inorganic growth post-acquisition? - Management indicated that the acquisition provides opportunities for bolt-on acquisitions and organic growth due to a larger global footprint and enhanced capabilities [30][31] Question: What areas are driving the guidance change? - Management noted significant revisions in North America on-highway build rates and OEM responses to market demand conditions as key factors influencing the guidance change [37][39] Question: Can you discuss margin guidance and pricing expectations? - Management highlighted that pricing was strong in the quarter, with expectations for continued positive pricing tailwinds, although volume deterioration is anticipated [48][50] Question: What is the outlook for the service parts business in the second half? - Management expects stable trends in service requirements, although demand for support equipment may decrease due to lower volumes [72]

Financial Data and Key Metrics Changes - Revenue grew 73% year over year to $545 million, with an adjusted EBITDA margin above 15% [28][39] - Subscribers increased by 73,000 quarter over quarter to over 2.4 million, reflecting a year-over-year growth rate of 31% [28] - Monthly average revenue per subscriber declined quarter over quarter to $74 from $84, primarily due to offboarding GLP-1 subscribers [30][39] Business Line Data and Key Metrics Changes - Strong performance in dermatology, oral weight loss, and daily sexual health offerings, all sustaining year-over-year subscriber growth rates above 55% [28][29] - Continued success in the weight loss specialty, despite headwinds from offboarding GLP-1 subscribers [29][60] - Daily sexual health offerings are expected to improve retention and customer lifetime value [29] Market Data and Key Metrics Changes - The company is expanding its presence in the UK through the acquisition of Zava, with plans to enter Canada in 2026 focusing on holistic weight loss programs [24][25] - Anticipated launch of generic semaglutide in Canada, expected to significantly reduce consumer price points and improve access [80] Company Strategy and Development Direction - The company aims to democratize access to precision medicine and expand into new specialties, including hormonal health [13][14] - Plans to integrate lab testing capabilities to enhance service offerings and support the hormonal health launch [16][17] - Focus on building a technology-first healthcare platform, leveraging AI for personalized care and operational efficiency [20][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the momentum of the business and the demand for personalized healthcare solutions [5][26] - The company anticipates continued growth in subscriber retention and engagement through personalized treatment plans [30][43] - Management acknowledged potential headwinds from the transition of the sexual health specialty but expects long-term benefits from daily offerings [29][60] Other Important Information - The company completed a convertible debt offering, strengthening its balance sheet with over $1.1 billion in cash and short-term investments [34] - Free cash flow for the second quarter was negative $69 million, but positive cash flow generation is expected in the second half of the year [35] Q&A Session Summary Question: Why was now the right time to expand internationally and what made Zava the right company to acquire? - Management believes it is a powerful opportunity to lead in personalized, high-touch, affordable precision medicine globally, with Zava's scalable platform being a key asset [45][47] Question: How does the launch of at-home lab testing improve the business? - Lab testing is seen as foundational for all categories, enabling a transition to preventative health and potentially leading to a membership model similar to Amazon or Costco [50][51] Question: Update on the HERS business performance and growth drivers? - The HERS business continues to grow robustly, driven by dermatology, weight loss, and upcoming hormonal support offerings [66] Question: How is the company approaching AI investments and expected returns? - The company aims for quick, tangible improvements through AI, enhancing efficiency and engagement across the platform [68] Question: Expectations for GLP-1 revenue and future growth? - Management expects continued growth in the weight loss specialty despite recent declines, with a focus on personalized offerings [72][73]

Financial Data and Key Metrics Changes - The company reported Q2 revenue of $124 million, which is up 3% from Q1 and flat compared to the same period last year [6][15] - Non-GAAP gross margin remained strong at 69.3%, with adjusted EBITDA expanding to 34.1% [7][16] - Non-GAAP EPS was $0.24, up from $0.22 in Q1 and $0.23 in the year-ago period [17] - GAAP net cash flow from operating activities increased to $38.5 million, up from $31.9 million in Q1 [17] - Free cash flow in Q2 was $31.3 million, with a free cash flow margin of 25.2%, up from $23.3 million and 19.4% in Q1 [17] Business Line Data and Key Metrics Changes - The communications and computing segment grew 20% sequentially and 26% year-over-year, with the server segment showing an 85% year-over-year growth [10][25] - Industrial and automotive segments declined sequentially, but the company expects to normalize channel inventory by year-end [11][12] - Total revenue from new products continues to grow at a strong rate, on track to exceed 2025 goals [12] Market Data and Key Metrics Changes - The company noted strong demand in communications and computing, driven by data center infrastructure [10] - Industrial and automotive segments are expected to recover, with significant growth anticipated in 2026 [11][40] - The company reported record design wins across all segments, indicating strong future demand [54] Company Strategy and Development Direction - The company continues to execute its long-term strategy, focusing on innovation and deepening customer engagements [13] - The management emphasized the importance of being a companion to AI accelerators and other advanced applications [9][97] - The company is committed to returning capital to shareholders while investing in growth opportunities [19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the market environment, citing strong demand in communications and computing [7][8] - The company is confident in its ability to navigate macro uncertainties and invest for future growth [19] - Management expects continued growth in revenue and profitability for Q3, with guidance of $133 million in revenue [12][20] Other Important Information - The company is debt-free and has access to capital for future investments [19] - Management highlighted the importance of maintaining strong gross margins and operational efficiency [16][31] Q&A Session Summary Question: Insights on companionship opportunities and data center infrastructure - Management believes the company is well-positioned to benefit from increased AI infrastructure spending as it exits 2025 and into 2026 [24][25] Question: Update on new products versus core products - The company is on track to exceed its forecast for new product revenue, expecting significant growth in 2026 [28] Question: Confidence in the business model and future opportunities - Management expressed strong confidence in the durability of the business model and the potential for growth in various sectors [35][36] Question: Revenue growth target for 2026 - The company confirmed that the 15% to 20% revenue growth target for 2026 remains viable [38][39] Question: Changes in customer order patterns in China - Management has not observed significant changes in order patterns despite geopolitical volatility [88][89] Question: Growth drivers in the AI infrastructure market - The company is seeing strong growth in AI-related revenue, with expectations for continued expansion [94][95] Question: Impact of tariffs on business - Management indicated that existing country-specific tariffs would supersede any new tariffs, minimizing potential impacts [102][104]

Financial Data and Key Metrics Changes - The second quarter revenue was $764 million, up 12% year-over-year, with organic revenue growth of 4% excluding acquisitions [19][20] - Adjusted EBITDA increased to $146 million, a 16% year-over-year growth, driven by strong performance in government operations [20][22] - Adjusted earnings per share rose to $1.02, reflecting a 24% increase, supported by lower tax rates and foreign currency gains [20][26] - Free cash flow for the quarter was robust at $126 million, aided by effective working capital management [21][26] Business Line Data and Key Metrics Changes - Government operations revenue grew by 9%, with adjusted EBITDA up 23% to $133 million, yielding an adjusted EBITDA margin of 22.6% [22][23] - Commercial operations reported revenue growth of 24%, but organic revenue was down 3%, primarily due to a decline in commercial power [23][24] - The backlog increased to $6 billion, a 23% quarter-over-quarter and 70% year-over-year growth, with organic book-to-bill at 2.2 [7][19] Market Data and Key Metrics Changes - Demand across global security, clean energy, and medical end markets is accelerating, with significant growth opportunities identified [6][28] - The naval propulsion business is expected to maintain a revenue CAGR of 3% to 5% over the long term, supported by recent pricing agreements [9][10] - The commercial power segment is experiencing strong demand, particularly in the Candu market, with ongoing life extensions and potential new builds [17][18] Company Strategy and Development Direction - The company is focused on enhancing capabilities in the nuclear market through both organic and inorganic investments, including the recent acquisition of Kinetrix [6][28] - Strategic priorities include operational excellence and expanding service offerings in nuclear power and energy infrastructure markets [6][10] - The company anticipates significant growth in advanced nuclear fuel opportunities and is well-positioned to capture emerging market demands [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong operational performance and backlog, indicating a positive outlook for the remainder of the year [28][26] - The company is raising its guidance for revenue, adjusted EBITDA, and earnings per share, reflecting better-than-expected operational performance [26][27] - Management noted that while the second half may see some normalization in performance, the overall operational conditions remain strong [102][103] Other Important Information - The company is actively pursuing advanced nuclear fuel opportunities and has received government support for various projects [11][90] - The recent reconciliation bill is expected to provide additional funding for nuclear programs, enhancing the company's growth prospects [90][91] Q&A Session Summary Question: Clarification on $29 million favorable contract adjustment - The $29 million relates to a special materials contract, with part included in the original guidance but more favorable than anticipated [31][32] Question: Opportunities for securing content on new build AP1000s - The company has an MOU with Westinghouse to potentially manufacture components for AP1000 reactors, with significant opportunities expected [33][34] Question: Impact of Kevin McCoy's appointment as Chief Nuclear Officer - Kevin McCoy is seconded to the Department of Defense, and his role is to assist with nuclear shipbuilding, while Joe Miller has been promoted to President of Government Operations [41][42] Question: Drivers of improved government operations margins - Margins were positively impacted by strong operating performance and favorable contract performance, with expectations for continued strong performance [42][43] Question: Revenue recognition for the first reactor in Darlington - Revenue for the X300 reactor is expected to be evenly distributed over a four-year period, with significant opportunities for additional reactors [92][93] Question: Growth in backlog and organic vs acquisition contributions - The majority of the backlog growth was organic, with approximately $240 million attributed to acquisitions [108] Question: Impact of critical minerals shortages - The company is not experiencing significant pressure from critical minerals, managing commodity risks effectively [109][110]

Financial Data and Key Metrics Changes - The company reported Q2 revenue of $669 million, a 33% year-over-year increase, marking the fourteenth consecutive quarter of over 25% revenue growth [25] - Adjusted gross margin was 63.3%, up 20 basis points year-over-year, driven by a favorable product mix towards software and services [27] - Adjusted EBITDA margin of 25.7% exceeded expectations due to higher revenue and operating leverage [28] Business Line Data and Key Metrics Changes - Software and services revenue grew 39% year-over-year to $292 million, while connected devices revenue increased 29% year-over-year to $376 million [25][26] - TASER product revenue grew 19%, driven by TASER 10, and personal sensors grew 24% due to Axon Body 4 [27] - The company closed nearly $150 million in bookings for its AI era plan in Q2, with over 30% of bookings coming from new product categories [22] Market Data and Key Metrics Changes - The international team added a new TASER customer in Africa, becoming the largest in the region, and signed a contract in the gaming space, marking its first win in that vertical [21] - The company expects to see continued growth in international markets, particularly in Latin America, the UK, Europe, and certain segments within Asia [66][71] Company Strategy and Development Direction - The company is focused on expanding its product portfolio and enhancing customer relationships, emphasizing collaboration in public safety [15][11] - Investments in R&D are prioritized to support a broad and cohesive product pipeline, with a commitment to innovation and customer satisfaction [29][16] - The company aims to increase hiring, particularly in R&D, to support its product roadmap and new market opportunities [28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving year-over-year bookings growth in the high 30% range, driven by strong execution and innovation [23] - The company raised its 2025 revenue guidance to a range of $2.65 to $2.73 billion, reflecting confidence in the pipeline for the second half of the year [28] - Management highlighted the importance of trust built with customers, which enables faster adoption of new solutions [14] Other Important Information - The company is experiencing strong demand for AI, drones, and robotics, with customers adopting new solutions more rapidly than in the past [11][12] - The company is seeing significant interest in its counter-drone solutions, driven by increasing awareness of drone threats [50][51] Q&A Session Summary Question: Can you discuss the enterprise addressable market and product traction? - Management noted strong interest across the full suite of products, including body cams, evidence management, and drones, indicating a positive trend in the enterprise market [31] Question: What is driving the high 30% bookings growth guidance? - Management attributed the growth to a diversified approach, selling new products to existing customers and existing products to new markets [65] Question: Can you provide details on international growth and key markets? - Management highlighted opportunities in Latin America, the UK, Europe, and certain segments in Asia, with significant momentum in international bookings [68][71] Question: What lessons have been learned regarding AI bookings? - Management emphasized the importance of user feedback and real-world application, which drives customer satisfaction and adoption [76] Question: What opportunities exist with federal government funding? - Management indicated that they expect to see more solicitations for products related to counter-drone technology and video products due to federal funding [79] Question: How is the company positioned in Europe? - Management noted rising visibility and interest in large deals, particularly in response to social challenges and security needs in Europe [84][88]

Financial Data and Key Metrics Changes - Real estate FFO was $3.05 per share in Q2 2025, a 4.1% increase from $2.93 in the prior year [10] - Domestic property NOI increased by 4.2% year over year for the quarter and 3.8% for the first half of the year [10] - Second quarter funds from operation were $1,190 million or $3.15 per share, compared to $1,090 million or $2.90 per share last year, reflecting an 8.6% growth [12] - The company raised its full year 2025 real estate FFO guidance range to $12.45 to $12.65 per share, up from $12.24 last year [15] Business Line Data and Key Metrics Changes - Approximately 1,000 leases were signed for over 3.6 million square feet in the quarter, with nearly 90% of leases expiring through 2025 completed [11] - Malls and premium outlets ended Q2 at 96% occupancy, up 10 basis points sequentially and 40 basis points year over year [11] - The mills achieved a record occupancy of 99.3%, an increase of 90 basis points sequentially and 110 basis points from the prior year [11] Market Data and Key Metrics Changes - Average base minimum rent for malls and outlets increased by 1.3% year over year, while mills increased by 0.6% [12] - Sales for malls and premium outlets per square foot were $736 for the quarter [12] - Traffic increased by 1.5%, although some centers near borders experienced sales and traffic weakness [70] Company Strategy and Development Direction - The company focuses on creating long-term value through disciplined investments and operational excellence [6] - The acquisition of Brickell City Center was highlighted as a strategic move to enhance operations and drive NOI growth [13] - The company is actively seeking additional acquisition opportunities while maintaining a selective approach based on product and price sensitivity [40][52] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the economic environment, acknowledging the impact of tariffs and geopolitical uncertainties [62] - Despite challenges, management noted that retail demand remains strong and traffic is increasing [24][66] - The company is optimistic about the growth profile of the U.S. economy, driven by significant planned capital investments [64] Other Important Information - The company announced a dividend of $2.15 per share for Q3, a year-over-year increase of $0.10 or 4.9% [15] - The company completed 21 secured loan transactions totaling approximately $3.8 billion, with a weighted average interest rate of 5.84% [14] Q&A Session Summary Question: Leasing velocity and demand insights - Management noted that retail demand is unabated despite geopolitical uncertainties, with strong traffic and sales performance [19][24] Question: Demand from smaller tenants - Management indicated that smaller tenants are performing well and beating their plans for the year, showing strong demand [30] Question: Acquisition opportunities and Brickell asset potential - Management expressed excitement about the Brickell acquisition, highlighting its strategic location and growth potential [36][39] Question: Economic outlook and guidance updates - Management remains cautious about the economic environment but is optimistic about the growth profile for 2026 [62][66] Question: Traffic growth quantification - Management reported a 1.5% increase in traffic, with some centers near borders experiencing challenges [70] Question: Supply and occupancy pipeline - Management indicated a focus on optimizing occupancy and tenant mix across all asset classes [76] Question: Interest in acquiring anchor boxes - Management clarified that while they are interested in acquiring anchor boxes, pricing and complexity of transactions are key considerations [88][90]

Financial Performance - In Q2, MercadoLibre reported revenue growth of over 30% year on year, with record income from operations of $825 million [4] - The company achieved accelerated GMV growth in June following the implementation of a new pricing strategy [5] - Advertising revenue grew by 38% year on year [5][6] Business Line Performance - Monthly active users of Mercado Pago reached 68 million, reflecting rapid user growth and increasing engagement [6] - The credit portfolio surpassed $9.3 billion, growing by 91% year on year, with a significant increase in credit card issuance [6][7] - The company reported that over half of its credit portfolio in Brazil is now NIM positive [8] Market Performance - In Brazil, the free shipping threshold was lowered for the third time in five years, which is expected to enhance user engagement and attract new customers [4][5] - Mexico experienced sharp GMV growth, with the number of items sold increasing at the fastest pace in almost two years [5] Strategic Direction and Industry Competition - The company is focused on bringing offline retail online by reducing frictions in the shopping experience [4] - There is a strong emphasis on integrating AI to improve marketing execution and advertising efficiency [21][22] Management Commentary on Operating Environment and Future Outlook - Management expressed confidence in the long-term benefits of recent strategic initiatives, including the lower free shipping threshold and reduced seller fees [11][12] - The company is optimistic about the quality of its credit business, with NPLs falling below 7% for the first time since reporting began [7] Other Important Information - The company is investing heavily in marketing, with sales and marketing spend up nearly 50% year on year, driven by high-profile campaigns [15][18] - The integration with Google Manager is seen as a key milestone for Mercado Ads [6] Q&A Session Summary Question: Shipping changes and seller fees impact - Management noted that lowering seller fees has a positive impact on pricing and selection over time [11][12] Question: Sales and marketing spend - Increased spend is attributed to successful campaigns, but it has put short-term pressure on margins [17][19] Question: Low ASP strategy compared to Shopee - The company believes it has the widest selection in Brazil and is encouraged by the traction from new sellers [25][26] Question: Shipping strategy in other countries - Management indicated that each market is different, and they will evaluate the implementation of similar policies in Mexico and Argentina [30][32] Question: GMV acceleration in Brazil - Items sold in Brazil grew by 34% year on year in June, indicating a positive trend following the free shipping campaign [35][36] Question: NPLs and asset quality - Management is satisfied with the evolution of NPLs and the profitability of credit portfolios, despite some increases in longer-term NPLs [42][43] Question: Advertising growth and performance - Advertising revenues grew significantly, with display and video ads showing strong performance [46][47] Question: Credit card business profitability - The credit card business in Brazil is now NIM breakeven, with expectations for future growth in Argentina [58][59] Question: Funding mix for credit portfolio - The company is transitioning to more external funding for its credit card portfolio, which may impact NIM in the future [62]